Additionally, the observation of heterogeneous alterations in BCL2 family proteins and a lack of consistency between expression and sensitivity to inhibition between resistant lines suggests that multiple mechanisms of venetoclax resistance develop in DLBCL. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.